Therachon SAS
1Patents
1Active
1Granted
40Portfolio score
Filing activity: Apr 2, 2018 → Apr 2, 2018
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10294289B2 | Soluble fibroblast growth factor receptor 3 (SFGFR3) polypeptides and uses thereof | Human Necessities | 5 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.